Vagus nerve stimulator

From WikiMD's WELLNESSPEDIA

The Vagus Nerve Stimulator (VNS) is a medical device used primarily to treat epilepsy and depression. It is implanted under the skin in the chest, with a wire (lead) that connects to the vagus nerve in the neck. The device sends electrical signals along the nerve to the brain.

History[edit]

The concept of vagus nerve stimulation for the treatment of epilepsy originated in the 1880s, but it was not until the late 20th century that the technology became a practical reality. The first human implantation of a VNS device took place in 1988, and the device was approved by the FDA in 1997 for use in treating epilepsy. In 2005, the FDA approved VNS for the treatment of depression.

Mechanism of Action[edit]

The exact mechanism by which VNS works is not fully understood. It is believed that the electrical stimulation of the vagus nerve sends signals to the brain that help to regulate abnormal electrical activity. This can help to reduce the frequency and severity of seizures in people with epilepsy, and improve mood in people with depression.

Uses[edit]

VNS is used primarily to treat epilepsy and depression. It may also be used in the treatment of other conditions, such as chronic pain, anxiety disorders, and obesity, although more research is needed in these areas.

Side Effects[edit]

Common side effects of VNS include hoarseness, shortness of breath, difficulty swallowing, and changes in voice. These side effects are usually mild and temporary, but can be more severe in some people.

Future Research[edit]

Future research into VNS is focused on improving the technology and expanding its uses. This includes research into the use of VNS in the treatment of other conditions, such as Alzheimer's disease, migraines, and heart failure.

See Also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.